Outcome of AGM
We submit herewith the proceedings details of the 50th Annual General Meeting of the Company held on Wednesday, May 31 2017 at Sunville Banquets,3rd Floor, Royal Room, Dr. Annie Besant Road, Worli, Mumbai -400 018 at 3 p.m. Pursuant to the requirements of Reg. 44 (3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 the voting results have been uploaded through XBRL on BSE website.... US FDA accepts application of Sun Pharma's partner Merck for tildrakizumab
Tildrakizumab is being evaluated for treatment of moderate-to-severe plaque psoriasis Outcome of Board Meeting
Reference your email dated May 17, 2017 stating that the 1st quarter financial results as filed by the Company are not in the format. We are enclosing herewith the same results in the revised format as per Schedule III of the Companies Act 2013. Trust you will find the same in order. Merck opens up Bengaluru centre for collaboration with Indian pharma firms
M Lab Collaboration centres to handhold Indian biotech units Merck expands M Lab Collaboration Center in Bengaluru
The world's oldest pharmaceutical and chemicals' company Merck on Friday announced the expansion of its M Lab Collaboration Center here. The facility will provide biopharmaceutical manufacturers with... Merck shares jump over 6% on strong Q4 results
Shares of drug firm Merck today soared over 6 per cent after the company reported a 76.42 per cent increase in net profit for the quarter ended March 31. After opening on a positive note, the... Outcome Of The Board Meeting Held Today.
With reference to the above captioned subject, we are enclosing herewith a copy of un-audited Financial Results along with the Limited Review Report for the quarter ended March 31, 2017 as approved by the Board of Directors of the Company at its meeting held on May 03, 2017. The Un-audited Financial Results will be published in the newspapers within the stipulated time as per the SEBI Listing Regulations. How a nimble Merck is building on a 349-year legacy
Family-owned German multinational Merck is poised for a twin milestone, clocking 50 years of business in India this year, and 350 years internationally next year. We tout that (the 349 years) a lot... Merck sells biosimilars business to Fresenius to focus on innovative drugs
Merck to receive upfront payment of 170 mn & milestone payments of up to 500 mn on future sales Board Meeting On May 03, 2017
In terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements), 2015 we wish to inform you that a meeting of the Board of Directors of the Company will be held on Wednesday, May 03 2017 interalia, to consider and approve the un-audited financial results for the quarter ended March 31, 2017.